Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY)

Clinical and Experimental Hypertension : CHE
Akinobu MaedaSatoshi Umemura

Abstract

Recent guidelines recommend combination antihypertensive therapy to achieve the target blood pressure (BP) and to suppress target organ damage. This study aimed to examine the beneficial effects of combination therapy with candesartan and amlodipine on BP control and markers of target organ function in Japanese essential hypertensive patients (N = 20) who did not achieve the target BP level during the monotherapy period with either candesartan or amlodipine. After the monotherapy period, for patients already being treated with amlodipine, a once-daily 8 mg dose of candesartan was added on during the combination therapy period (angiotensin II receptor blocker [ARB] add-on group, N = 10), and a once-daily 5 mg dose of amlodipine was added on for those already being treated with candesartan (calcium channel blocker [CCB] add-on group, N = 10). Combination therapy with candesartan and amlodipine for 12 weeks significantly decreased clinic and home systolic blood pressure (SBP) and diastolic blood pressure (DBP). In addition, the combination therapy was able to significantly reduce urine albumin excretion without decrease in estimated glomerular filtration ratio and resulted in significant improvements in brachial-ankle pulse wave v...Continue Reading

References

Aug 15, 1996·Annals of the New York Academy of Sciences·G ParatiG Mancia
Jul 24, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Akira YamashinaYoshio Yamamoto
Jan 14, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masato EtoYasuyoshi Ouchi
Jun 23, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Masato EtoYasuyoshi Ouchi
Sep 23, 2006·The Journal of Pharmacology and Experimental Therapeutics·Masarsu IwaiMasatsugu Horiuchi
Dec 28, 2006·Clinical and Experimental Hypertension : CHE·Kouichi TamuraSatoshi Umemura
Mar 17, 2007·Diabetes Care·UNKNOWN Shiga Microalbuminuria Reduction Trial (SMART) GroupAtsunori Kashiwagi
May 19, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kenji TakazawaAkira Yamashina
Jan 4, 2008·Hypertension·Toshio OgiharaUNKNOWN Candesartan Antihypertensive Survival Evaluation in Japan Trial Group
Dec 5, 2008·The New England Journal of Medicine·Kenneth JamersonUNKNOWN ACCOMPLISH Trial Investigators
Mar 6, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Toshio OgiharaUNKNOWN COLM study investigators
Aug 22, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Toshihiko IshimitsuHiroaki Matsuoka
Aug 29, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shin-ichiro MasudaSatoshi Umemura
Mar 17, 2010·Lancet Neurology·Peter M RothwellUNKNOWN ASCOT-BPLA and MRC Trial Investigators
Mar 25, 2011·Journal of Hypertension·Efstathios ManiosNikolaos Zakopoulos
Jul 15, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Mohammad-Reza RezaiJohn Kennedy Cruickshank

❮ Previous
Next ❯

Citations

Jul 16, 2013·Clinical and Experimental Hypertension : CHE·Hisashi MasugataFuminori Goda
Sep 30, 2014·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Lu LuHai-Li Xin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.